307 related articles for article (PubMed ID: 15992948)
1. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation.
Ohara K; Inoue H; Nozawa T; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2008 Jun; 126(3):316-21. PubMed ID: 17689760
[TBL] [Abstract][Full Text] [Related]
3. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
4. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
[TBL] [Abstract][Full Text] [Related]
5. D-dimer levels in combination with clinical risk factors can effectively predict subsequent thromboembolic events in patients with atrial fibrillation during oral anticoagulant therapy.
Sadanaga T; Kohsaka S; Ogawa S
Cardiology; 2010; 117(1):31-6. PubMed ID: 20881392
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation.
Duygu H; Barisik V; Kurt H; Turk U; Ercan E; Kose S
Europace; 2008 Feb; 10(2):210-4. PubMed ID: 18184662
[TBL] [Abstract][Full Text] [Related]
7. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation.
Habara S; Dote K; Kato M; Sasaki S; Goto K; Takemoto H; Hasegawa D; Matsuda O
Eur Heart J; 2007 Sep; 28(18):2217-22. PubMed ID: 17716991
[TBL] [Abstract][Full Text] [Related]
8. Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience.
Thibault B; Talajic M; Dubuc M; Guerra P; Gagné P; Roy D; Connolly S;
Can J Cardiol; 2004 Feb; 20(2):195-9. PubMed ID: 15010743
[TBL] [Abstract][Full Text] [Related]
9. D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation.
Krarup LH; Sandset EC; Sandset PM; Berge E
Acta Neurol Scand; 2011 Jul; 124(1):40-4. PubMed ID: 20726843
[TBL] [Abstract][Full Text] [Related]
10. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation.
Watson T; Shantsila E; Lip GY
Int J Cardiol; 2007 Aug; 120(1):123-4; author reply 125-6. PubMed ID: 17055595
[No Abstract] [Full Text] [Related]
11. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy.
Sadanaga T; Sadanaga M; Ogawa S
J Am Coll Cardiol; 2010 May; 55(20):2225-31. PubMed ID: 20466203
[TBL] [Abstract][Full Text] [Related]
12. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
13. Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation.
Nozawa T; Inoue H; Iwasa A; Okumura K; Jong-dae L; Shimizu A; Hayano M; Yano K
Circ J; 2004 Jan; 68(1):29-34. PubMed ID: 14695462
[TBL] [Abstract][Full Text] [Related]
14. Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation.
Boulanger L; Hauch O; Friedman M; Foster T; Dixon D; Wygant G; Menzin J
Ann Pharmacother; 2006 Jun; 40(6):1024-9. PubMed ID: 16735649
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
Blich M; Gross B
Int J Cardiol; 2004 Jul; 96(1):89-95. PubMed ID: 15203266
[TBL] [Abstract][Full Text] [Related]
16. Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism.
Inoue H; Nozawa T; Okumura K; Jong-Dae L; Shimizu A; Yano K
Chest; 2004 Sep; 126(3):687-92. PubMed ID: 15364743
[TBL] [Abstract][Full Text] [Related]
17. [Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
J Cardiol; 1998 Apr; 31(4):227-38. PubMed ID: 9594372
[TBL] [Abstract][Full Text] [Related]
18. Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy.
Sallah S; Husain A; Sigounas V; Wan J; Turturro F; Sigounas G; Nguyen NP
Clin Cancer Res; 2004 Nov; 10(21):7238-43. PubMed ID: 15534097
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population.
Currie CJ; McEwan P; Emmas C; Morgan CL; Peters JR
Curr Med Res Opin; 2005 Dec; 21(12):1905-13. PubMed ID: 16368039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
